|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 66.79 EGP | +1.20% |
|
+1.07% | +18.11% |
Kahira Pharmaceuticals & Chemical Industries Company reported earnings results for the nine months ended March 31, 2024. For the nine months, the company reported sales was EGP 1,045.11 million compared to EGP 665.55 million a year ago. Net income was EGP 195.07 million compared to EGP 56.05 million a year ago.
Basic earnings per share from continuing operations was EGP 13.06 compared to EGP 3.75 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +18.11% | 20.77M | |
| +55.32% | 815B | |
| -6.75% | 352B | |
| +13.56% | 314B | |
| +10.68% | 303B | |
| +16.57% | 242B | |
| +2.04% | 224B | |
| +13.31% | 218B | |
| +8.48% | 168B | |
| -2.81% | 159B |
KAHIRA PHARMACEUTICALS & CHEMICAL INDUSTRIES COMPANY 
